Cite
No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study
MLA
Margaux Lafaurie, et al. “No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study.” Blood, vol. 134, Nov. 2019, p. 2363. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........56bd75d32d729eba56fea0bf50cf6358&authtype=sso&custid=ns315887.
APA
Margaux Lafaurie, Agnès Sommet, Maryse Lapeyre-Mestre, Myriam Cassagne, Guillaume Moulis, Bérangère Baricault, Vincent Soler, & Laurent Sailler. (2019). No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study. Blood, 134, 2363.
Chicago
Margaux Lafaurie, Agnès Sommet, Maryse Lapeyre-Mestre, Myriam Cassagne, Guillaume Moulis, Bérangère Baricault, Vincent Soler, and Laurent Sailler. 2019. “No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study.” Blood 134 (November): 2363. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........56bd75d32d729eba56fea0bf50cf6358&authtype=sso&custid=ns315887.